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Timing of cell differentiation is strictly controlled and
is crucial for normal development and stem cell
differentiation. However, underlying mechanisms
regulating differentiation timing are fully unknown.
Here, we show a molecular mechanism determining
differentiation timing from mouse embryonic stem
cells (ESCs). Activation of protein kinase A (PKA)
modulates differentiation timing to accelerate the
appearance of mesoderm and other germ layer cells,
reciprocally correlated with the earlier disappear-
ance of pluripotent markers after ESC differentia-
tion. PKA activation increases protein expression of
G9a, an H3K9 methyltransferase, along with earlier
H3K9 dimethylation and DNA methylation in Oct3/4
and Nanog gene promoters. Deletion of G9a com-
pletely abolishes PKA-elicited acceleration of differ-
entiation and epigenetic modification. Furthermore,
G9a knockout mice show prolonged expressions
of Oct3/4 and Nanog at embryonic day 7.5 and
delayed development. In this study, we demonstrate
molecular machinery that regulates timing of
multilineage differentiation by linking signaling with
epigenetics.
INTRODUCTION
Embryonic development is a highly orchestrated process, and
the timing of cell differentiation from stem cells during develop-
ment is strictly controlled. Nevertheless, the underlying molec-
ular mechanism regulating differentiation timing remains
unknown. Embryonic stem cells (ESCs), which are derived
from the inner cell mass (ICM) of early blastocysts and are able
to differentiate from a pluripotent state into all three germ layer
populations in vitro, are one of the most potent tools for investi-
gating cell-differentiation processes (Evans and Kaufman, 1981;
Martin, 1981; Thomson et al., 1998). Even though numerous
methods have been reported to induce ESC differentiationin vitro, currently the timing of differentiated cell emergence
from ESCs cannot be intentionally controlled. Cell differentiation
is often compared to a ball rolling down an epigenetic landscape
from the pluripotent state to lineage-committed states (Wad-
dington, 1957; Yamanaka, 2009). Though the destination and
route of the ball (i.e., nerve, cardiomyocyte, liver, etc.) has
been intensively investigated, the timing of differentiation—that
is, arrival time to the destination—has not been highlighted and
remains an open question.
Histone methylation contributes to chromatin remodeling as
well as transcriptional activity and operates the epigenetic land-
scape. Methylation of lysine 9 of histone H3 (H3K9) is a well-
conserved epigenetic mark for heterochromatin formation and
transcriptional silencing (Jenuwein, 2006). G9a (Ehmt2) is an
H3K9 methyltransferase (mainly mono- and dimethylation, me1
and me2) of euchromatin (Tachibana et al., 2002; Tachibana
et al., 2005). Recent studies on the mouseOct3/4 gene, a plurip-
otent gene, have demonstrated that the postimplantation inacti-
vation process ofOct3/4 is carried out in amultilayer manner that
involves direct inhibition of transcription, heterochromatiniza-
tion, through the methylation of H3K9 by G9a and subsequent
DNA methylation (Feldman et al., 2006). Furthermore, G9a itself
is capable of causing de novo DNA methylation to be indepen-
dent of its histone methyltransferase activity by recruiting DNA
methyltransferases Dnmt3a and Dnmt3b. These events should
cause irreversible silencing of Oct3/4 in differentiated cell line-
ages (Epsztejn-Litman et al., 2008). G9a-deficient mice dis-
played severe growth retardation and early lethality (Tachibana
et al., 2002), indicating that cell differentiation would be affected
by the inhibition of pluripotent factors through epigenetic modi-
fication in early differentiation. Nevertheless, the regulatory
mechanisms of most epigenetic modifiers, including G9a, and
the involvement of them in differentiation kinetics are yet
unknown.
Previously, we developed an ESC differentiation system that
recapitulates early cardiovascular development in vitro (Nishi-
kawa et al., 1998; Yamashita et al., 2000; Yamashita et al.,
2005). Flk1 (also known as vascular endothelial growth factor
[VEGF] receptor-2) is one of the earliest differentiation markers
for endothelial cells (ECs) and blood cells, and it is a marker of
lateral plate mesoderm (Nishikawa et al., 1998; Yamashita
et al., 2000). We induced Flk1+ cells from ESCs, and they wereCell Stem Cell 10, 759–770, June 14, 2012 ª2012 Elsevier Inc. 759
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recultured. We succeeded in inducing the major cardiovascular
cell types from the common Flk1+ progenitor cells: vascular
ECs, mural cells (pericytes and vascular smooth muscle cells)
(Yamashita et al., 2000), and cardiomyocytes (Yamashita et al.,
2005). We recently reported that the activation of cyclic adeno-
sine monophosphate (cAMP)/protein kinase A (PKA) signaling
in Flk1+ cells markedly enhanced EC differentiation (Yamamizu
et al., 2009). cAMP/PKA signaling plays an important role
beyond vasculature in virtually every known physiological action,
such as metabolism, gene expression, cell division and growth,
and cell differentiation. Adenylate cyclase generates cAMP from
ATP in essentially all tissues of the body. This enzyme is acti-
vated by transmembrane receptors that are coupled to trimeric
G-proteins (Howe, 2004). The effects of cAMP are mediated
mainly by PKA. Mice deficient in PKA catalytic subunits (both
Ca and Cb) displayed early embryonic lethality around gastrula-
tion (Huang et al., 2002), and in Drosophila, genetically induced
mutations in the PKA catalytic subunits resulted in severe devel-
opmental defects (Lane and Kalderon, 1993; Lane and Kalderon,
1995), indicating that the PKA pathway is crucial in early
development. However, the roles of the cAMP/PKA pathway in
early development and stem cell differentiation are not fully
elucidated.
In this study, we attempt to elucidate roles of PKA signaling in
early-stage cell differentiation.We demonstrate that activation of
PKA regulates the timing of differentiation in ESCs and early
embryos through epigenetic inhibition of pluripotent gene
expression by G9a.
RESULTS
PKA Accelerates Differentiation Timing of the Three
Germ Layers from ESCs
To investigate the roles of the cAMP/PKA pathway in early differ-
entiation from ESCs, we first measured intracellular cAMP
concentration during ESC differentiation. Interestingly, intracel-
lular cAMP concentration significantly increased from differenti-
ation day-2.5 (D2.5) preceding the emergence of the three germ
layers (aroundD3.5) (Figure 1A).We then tried tomanipulate PKA
signaling during ESC differentiation. We generated an ESC line
carrying a constitutive active form of the PKA (CA-PKA) gene,
which can be induced with the depletion of tetracycline (Tet-
Off system) (Yamamizu et al., 2009), and activated the PKA
pathway from the beginning of ESC differentiation (Figure 1B).
In the control condition (Dox+), the appearance of Flk1+ meso-
derm cells occurs from day 3.5 (D3.5) in our system. To our
surprise, when PKA was activated (Dox) from D0, Flk1+ cells
were able to be observed from D1.5 and became more promi-
nent in the following 2 days (Figures 1C and 1D). A similar amount
of Flk1+ cells were detected approximately two times faster with
PKA activation compared to the control condition. In contrast,
SSEA1+ cells, an undifferentiated ESC marker, were decreased
significantly from D1.5 by CA-PKA expression (Dox) (Figures
1C and 1E). Another mesoderm marker, platelet-derived growth
factor receptor-a (PDGFRa), was also increased significantly
earlier with PKA activation (Figures 1F and 1G). Double immu-
nostaining for Flk1 and SSEA1 similarly revealed an early
decrease in SSEA1 and a reciprocal early appearance of Flk1.760 Cell Stem Cell 10, 759–770, June 14, 2012 ª2012 Elsevier Inc.Flk1 expression was first detected from D1.5 in the Dox condi-
tion, compared to D3.5 in the control condition. In contrast,
SSEA1 expression completely disappeared at D3.5 in the
Dox condition when it was still predominant in the control
condition (Dox+) (Figure 1H). Immunostaining of brachyury,
a mesendoderm marker, also showed an apparent earlier
appearance with PKA activation than in the control condition
(Figure 1I). RT-PCR and quantitative RT-PCR (qPCR) showed
that emergence and peak expression of brachyury, Flk1, and
PDGFRa mRNA were accelerated by PKA activation. Inversely,
when endogenous PKA was blocked by treatment with a PKA
inhibitor, PKI, the mRNA expression of these markers was de-
layed in comparison to the control condition (Figures 1J and
1K). These results indicate that PKA activity in early differenti-
ating ESCs regulates differentiation timing from ESCs to meso-
derm cells.
Next, we examined endoderm and ectoderm induction from
ESCs with PKA activation. Induction of Foxa2+ endoderm cells
appeared from D3.5 in the control condition. In contrast, PKA
activation significantly increased an earlier appearance of
Foxa2+ cells from D2.5 (Figures 2A and 2B). Nuclear expression
of definitive endoderm markers, Foxa2 and Sox17, was
observed in distinct populations at D1.5 and increased in the
following 2 days under PKA activation (Dox), whereas these
expressions were still sparse at D3.5 in the control condition
(Figures 2C and 2D). RT-PCR and qPCR revealed an earlier
emergence and peak expression of Foxa2 and Sox17 mRNA
by PKA activation and an inverse delay in their expressions
with PKI treatment (Figures 2E and 2F). Appearance of an ecto-
derm marker protein, Nestin, was also induced significantly
earlier than in the control condition by PKA activation (Figures
2G–2I). mRNA expression kinetics of ectoderm markers, Nestin
and Fgf5, was similarly modified in accordance with PKA activa-
tion or inhibition (Figures 2J and 2K). Thus, differentiation timing
of ESCs to all three germ layer cells was positively regulated by
PKA activity.
As proliferation and differentiation are considered to be
closely related to each other, we examined cell proliferation
during ESC differentiation under PKA activation (Figure S1).
Total cell counts were not different between the Dox+ condition
and the Dox condition. In particular, the cell number was
almost completely identical until D2.5, when early appearance
of germ layer cells has already been achieved. EdU (an analog
of BrdU) incorporation also showed that overall cell pro-
liferation was not affected by PKA activation during ESC differ-
entiation. Taken together, these results indicate that PKA
should accelerate differentiation timing of the three germ layers
from mouse ESCs with independent mechanisms from cell
proliferation.
PKA Activation Accelerates Disappearance of
Pluripotent Markers after Differentiation
Next, we examined the undifferentiated status of ESCs after
differentiation induction under PKA activation. In the control
condition (Dox+), alkaline phosphatase (AP)-negative differenti-
ated colonies appeared from D3.5. In contrast, PKA activation
(Dox) induced the appearance of AP-negative colonies from
D1.5. They showed various cellular morphologies, such as endo-
derm- or mesoderm-like cells, in the following 2 days (Figures 3A
Figure 1. PKA Accelerates Differentiation Timing
of Mesodermal Cells from ESCs
(A) Intracellular cAMP concentration during ESC differen-
tiation (n = 3, **p < 0.01 versus undifferentiated cells).
(B) Experimental system for PKA activation. ESC lines
expressing a constitutive active form of PKA (CA-PKA) via
a tetracyclin-inducible expression system (Tet-Off) were
established.
(C) Time course of Flk1+ or SSEA1+ cell appearance
evaluated by FACS. PKAwas activated from the beginning
of ESC differentiation. Upper panels: Dox treatment
(1 mg/ml; Dox+; control). Lower panels: Dox free (Dox;
PKA activation). Percentages of Flk1+ or SSEA+ cells in
total cells are indicated.
(D and E) Quantitative evaluation of effects of PKA acti-
vation on Flk1+ or SSEA1+ cell appearance during ESC
differentiation. Percentages of the Flk1+ (D) or SSEA1+ (E)
population (n = 3; *p < 0.05, **p < 0.01 versus Dox+) are
indicated.
(F) FACS analysis for PDGFRa+ cell appearance.
Percentages of PDGFRa+ in total cells are indicated.
(G) Quantitative evaluation of PDGFRa+ cell percentages
(n = 3; **p < 0.01 versus Dox+).
(H) Double immunostaining for Flk1 (green) and SSEA1
(red) during ESC differentiation. Upper panels: Dox+.
Lower panels: Dox. Scale bar represents 200 mm.
(I) Immunostaining for Brachyury (green). Scale bar
represents 200 mm.
(J and K) RT-PCR (J) and qPCR (K) showing mRNA
expression of Brachyury, Flk1, and PDGFRa during ESC
differentiation. Blue lines, Dox+ (control); red lines, Dox
(PKA activation); green lines, Dox+ with PKA inhibitor, PKI,
treatment (10 mM).
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Figure 2. PKAAccelerates Differentiation Timing of Endodermal and
Ectodermal Cells from ESCs
(A and B) Quantitative evaluation of effects of PKA activation on Foxa2+ cell
appearance during ESC differentiation. (A) FACS analysis for Foxa2+ cell
appearance. Percentages of Foxa2+ in total cells are indicated. (B) Quantitative
evaluation of Foxa2+ cell percentages (n = 3; *p < 0.05, **p < 0.01 versus Dox+).
(C and D) Immunostaining for Foxa2 (green, C) and Sox17 (green, D) during
ESC differentiation. Upper panels: Dox+. Lower panels: Dox. Scale bar
represents 200 mm.
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markers, Oct3/4 and Nanog, also revealed an earlier disappear-
ance of these proteins with PKA activation (Figures 3C and 3D).
mRNA expression of Oct3/4, Nanog, and Sox2 was decreased
earlier with PKA activation than in the control condition (Figures
3E and 3F). On the contrary, inhibition of endogenous PKA with
PKI treatment delayed the disappearance of these gene
expressions.
Next, we examined the effect of PKA activation on the mainte-
nance of undifferentiated status in the presence of leukemia
inhibitory factor (LIF). ESC growth was not affected by PKA acti-
vation. In addition, these cells maintained pluripotent gene
expressions until 4 weeks after activation (Figures S2A–S2C),
indicating that PKA itself is not able to initiate ESC differentiation
when the maintenance machinery is working. Taken together,
these results indicate that PKA accelerates the disappearance
of pluripotent genes after the exit from undifferentiated status
but cannot initiate ESC differentiation.
PKA Induces H3K9me2 and DNA Methylation through
G9a in Early Differentiation from ESCs
Our data show that PKA is broadly involved in many gene
expressions during ESC differentiation. Thus, we hypothesized
that the PKA pathway could be responsible for the regulation
of epigenetic modifications. We examined the overall status of
several histone H3 methylations during ESC differentiation.
Among those that we tested, H3K9me2 showed a remarkable
increase from D1.5 with PKA activation (Figure 4A). We then
examined the expression of an H3K9 dimethyltransferase,
G9a, during ESC differentiation, and we found that G9a protein
was significantly increased in the very early stages of differenti-
ation with PKA activation, from D0.5 to D2.5, which precedes
H3K9me2 (Figures 4B and 4C).
Early downregulation of pluripotent gene expression (i.e.,
Oct3/4, Nanog, and Sox2) and increase in an inhibitory epige-
netic marking (H3K9me2) suggest epigenetic silencing of these
pluripotent gene expressions via PKA. We then confirmed the
epigenetic markings in the promoter regions of Oct3/4 and
Nanog. A chromatin precipitation assay (ChIP) revealed that
H3K9me2 was significantly increased in the promoter regions
of Oct3/4 and Nanog from D1.5 after CA-PKA expression (Fig-
ure 4D). Bisulfate sequence analysis showed that PKA activa-
tion apparently increased DNA methylation in the promoter
regions of Oct3/4 and Nanog at D5.5 (Figures 4E and 4F). These
results suggest that PKA increases G9a protein level in the
early stages of differentiation, thereby enhancing H3K9me2
and subsequent DNA methylation in the promoter regions of
Oct3/4 and Nanog.(E and F) RT-PCR (E) and qPCR (F) showing mRNA expression of Foxa2 and
Sox17 during ESC differentiation. Blue lines, Dox+; red lines, Dox; green
lines, Dox+ with PKI treatment.
(G) FACS analysis for Nestin+ cell appearance. Percentages of Nestin+ in total
cells are indicated.
(H) Quantitative evaluation of Nestin+ cell percentages (n = 3; *p < 0.05,
**p < 0.01 versus Dox+).
(I) Immunostaining for Nestin (red). Scale bar represents 200 mm.
(J and K) RT-PCR (J) and qPCR (K) showing mRNA expression of Nestin
and Fgf5.
Figure 3. PKA Regulates Undifferentiated
Status during Differentiation from ESCs
(A) Alkaline phosphatase (AP) staining (purple)
during ESC differentiation. Upper panels: Dox+.
Lower panel: Dox. Scale bar represents 100 mm.
Arrow indicates the early appearance of AP-
negative cells. Arrowhead indicates cells with
endodermal-like morphology.
(B) Morphological evaluation of ESC colonies after
PKA activation. Black bars, undifferentiated colo-
nies; gray bars, partially differentiated colonies;
white bars, totally differentiated colonies (n = 3).
(C and D) Immunostaining for Oct3/4 (red, C) and
Nanog (green, D) during ESC differentiation. Upper
panels: Dox+. Lower panels: Dox. Scale bar
represents 200 mm.
(E and F) RT-PCR (E) and qPCR (F) showing mRNA
expression of Oct3/4, Nanog, and Sox2 during
ESC differentiation. Blue lines, Dox+; red lines,
Dox; green lines, Dox+ with PKI treatment.
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on G9a
To investigate whether regulations of differentiation timing by
PKA are G9a-mediated effects, we established an ESC line
carrying a dual inducible system combining tetracycline-regulat-
able CA-PKA expression and a tamoxifen (OHT)-inducible G9a
conditional knockout (cKO) system by using a fusion protein
(MerCreMer) of Cre protein andmutant estrogen receptor, which
has a single copy of the G9a gene flanked by loxP recombination
sites (/flox) (Yokochi et al., 2009) (Figures 5A and S3A). The
addition of an estrogen receptor ligand, 4-hydroxytamoxifen
(OHT), induced the rapid deletion of G9a and subsequent
H3k9me2 reduction (Figure 5B). Earlier PDGFRa+ mesoderm
appearance induced by PKA activation (Dox) was almost
completely abolished by the deletion of G9a (OHT+) (Figure 5C).
Similarly, PKA-elicited early brachyury (Figure 5D) and Flk1 (dataCell Stem Cell 10, 759–7not shown) appearances were abolished
in the absence of G9a. qPCR performed
on the mRNAs of these genes demon-
strated that under the G9a-deleted condi-
tion (OHT+), mRNA expression showed
delayed patterns similar to those shown
under treatment with PKA inhibitor (Fig-
ure 1K), and more importantly, effects of
PKA activation (Dox) were completely
abolished (Figure 5E). G9a deletion also
completely abolished PKA-elicited accel-
eration of differentiation to endoderm
(foxa2 and sox17) and ectoderm (nestin
and fgf5), examined with immunostaining
and qPCR (Figures 5F–5I). On the con-
trary, early disappearance of pluripotent
genes induced by PKA activation was
cancelled with G9a deletion (Figures 5J
and 5K). Moreover, bisulfate sequence
analysis revealed that G9a deletion abol-
ished PKA-elicited DNA methylation on
the promoter regions of Oct3/4 andNanog (Figures 5L and 5M). These results indicate that the accel-
eration of differentiation timing induced by PKA is mediated
by G9a.
PKA and G9a Regulate Differentiation Timing In Vivo
Finally, we examined the functional relevance of PKA and G9a in
differentiation timing in vivo. First, we confirmed PKA expression
in the early embryo. Immunostaining ofmouse embryos revealed
that the PKA catalytic subunit (PKAc) was highly expressed in
metaphase II-(MII) oocytes and in the 1-cell (1C) stage of the
zygote. PKAc once decreased from the 2-cell (2C) stage to the
compact morula stage, and it intensified at blastocyst stages
in both inner cell mass (ICM) and trophectoderm (TE) (Figure 6A).
qPCR for PKAc further revealed that PKAc was highly expressed
at the MII and 1C stages, once decreased at the 2C stage, and
was reupregulated at blastocyst stages (Figure 6B), indicating70, June 14, 2012 ª2012 Elsevier Inc. 763
Figure 4. PKA Regulates G9a Expression Accom-
panied by H3K9me2 and DNA Methylation in Early
Differentiation from ESCs
(A) Western blot for various histone methylations during
ESC differentiation. Upper panels: Dox treatment (Dox+).
Lower panel: Dox-free (Dox).
(B) Western blot for G9a during ESC differentiation.
(C) Quantitative evaluation of G9a protein expression.
Relative expression normalized with b-actin expression is
shown. Blue line, Dox+; red line, Dox (n = 3; **p < 0.01
versus Dox+).
(D) ChIP assays for H3K9me2 on Oct3/4 (left panels) or
Nanog (right panels) promoter regions. Lower panels show
quantitative evaluation of H3K9me2 (n = 3; **p < 0.01
versus Dox+).
(E and F) DNA methylation in the promoter regions of
Oct3/4 (E) and Nanog (F) with bisulfite genomic
sequencing. Open circles, nonmethylated CpGs; closed
circles, methylated CpGs.
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We confirmed the functional significance of PKA and G9a in the
early differentiation of the mouse embryos with an early blasto-
cyst culture assay (from embryonic day 3.25 [E3.25] to E4.75)
in the presence of a PKA inhibitor, H89, or a G9a inhibitor, BIX
01294. The E3.25 embryos that were collected were at approx-
imately the 32-cell stage and did not express Gata4, a primitive
endoderm marker (data not shown). After 1.5 days of treatment764 Cell Stem Cell 10, 759–770, June 14, 2012 ª2012 Elsevier Inc.in E3.25 embryos, immunostaining revealed
that the addition of H89 (3 mM) or BIX01294
(0.5 mM) significantly increased Nanog+ cells in
compared to control embryos (Figures 6C
and 6D). Whereas a clear array of Gata4+ primi-
tive endoderm cells was observed in control
embryos, H89 or BIX01294 treatment remark-
ably inhibited Gata4+ cell appearance (Figures
6E and 6F). Oct3/4+ cell number was not
affected with the inhibitor treatments, which
could be due to the fact that Oct3/4 was ex-
pressed in both ICM and primitive endoderm
at that stage. The total cell number after
BIX01294 treatment was decreased (Figures
6E and 6F). These results suggested that phys-
iological PKA and G9a critically control the
timing of early differentiation from ICM.
We further confirmed the in vivo functional
significance of G9a in differentiation timing
with G9a KO mice. We previously generated
G9a KO mice that displayed severe growth
retardation and died at E8.5–E12.5 (Tachibana
et al., 2002). Thus, we hypothesized that the
loss of G9a induced prolongation of Oct3/4
and Nanog expression and perturbed differenti-
ation in early embryos. We performed in situ
hybridization for Oct3/4 and Flk1 in early
embryos. At E6.5, Oct3/4 was highly expressed
in the distal side of the embryos (Figure 6G).
Wild-type (WT) E7.5 embryos showed only
a trace of Oct3/4 expression (Figure 6H, arrow),but Flk1 was expressed in wedge-shaped areas on the proximal
lateral sides (Figure 6H). G9a KO embryos at E7.5 showed
growth-retarded embryonic morphology and sustained expres-
sions of Oct3/4 in the whole embryo proper (Figure 6H, arrow-
heads) together with decreased Flk1 expression (Figure 6H)
(detailed results are shown in Figure S4). qPCR using whole
WT and G9a KO embryos at E7.5 further demonstrated the
remarkable increase in Oct3/4 and Nanog mRNA in the E7.5
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expression (Figure 6I). Both Oct3/4 and Nanog mRNA expres-
sion were decreased from E8.5 to E9.5 in G9a KO embryos
(data not shown). Taken together, these results indicate that
PKA and G9a should be regulating the differentiation timing
from early pluripotent cells in the embryo.
DISCUSSION
In this study, we demonstrated a molecular mechanism regu-
lating differentiation timing. PKA signaling accelerates the differ-
entiation timing of three germ layer cells through an H3K9
methyltransferase, G9a expression. G9a modified H3K9me2 in
the promoter region of Oct3/4 and Nanog, thereby inhibiting
Oct3/4 and Nanog transcription and in turn inducing earlier
differentiation (Figure 7). Elucidation of these functional linkages
from signaling (PKA) to epigenetic modification (G9a) to gene
expression (Oct3/4 and Nanog) and finally to cell behavior (differ-
entiation) would provide a valuable insight regarding the under-
lying machinery in the finely regulated stem cell differentiation
and orchestrated embryonic development.
The striking observations are the broad control of the differen-
tiation of the three germ layers by PKA signaling. Although
various growth factors such as BMPs, Wnts, and Fgfs play
important functions in cell-fate determination, PKA is here iden-
tified as a signal that commonly regulates differentiation timing
toward various cell fates. Currently, upstream signals involved
in the activation of the cAMP/PKA pathway in this process are
still unknown. We previously revealed that adrenomedullin (AM)
is one of the regulatory factors activating cAMP/PKA signaling
and enhances endothelial cell differentiation from Flk1+ vascular
progenitors (Yurugi-Kobayashi et al., 2006). We examined
whether AM could be an endogenous ligand that regulates differ-
entiation timing. mRNAs from AM and its receptors, RAMP3
(receptor activity modifying protein 3) and CRLR (calcitonin
receptor-like receptor), were detected in the early ESC differen-
tiation stage. Treatment of ESCs with AM weakly but positively
enhanced an early appearance of three germ layers and a recip-
rocal disappearance of pluripotent markers after ESC differenti-
ation (Figures S5A–S5L). Li et al. reported that preimplanting
blastocysts at E3.5 expressed AM in ICM and trophectoderm
cells (Li et al., 2006). We confirmed that AM was highly induced
from the 8-cell stage during embryogenesis (Figure S5M), sug-
gesting that an AM ligand-receptor system should exist and
act in the early stages of development. Taken together, AM could
be at least one of the endogenous ligands that activate cAMP/
PKA signaling for the regulation of differentiation timing in the
early developmental stage.
Though G9a was demonstrated to be downstream of PKA for
differentiation timing, it is still unclear how G9a expression is
regulated by PKA. We further investigated the relationship
between PKA and G9a expression by examining the role of
a major PKA downstream transcription factor, cAMP-response
element binding protein (CREB). We generated an ESC line
with an OHT-inducible dominant-negative form CREB (DN-
CREB) activation system (Figure S6A). Inhibition of CREB with
OHT treatment did not affect the protein level of G9a (Fig-
ure S6B). Furthermore, qPCR showed that PKA activation did
not affect the G9a mRNA level during ESC differentiation (Fig-ure S6C), indicating that PKA does not regulate G9a expression
through transcriptional regulation with CREB. APC/CCdh1 ubiqui-
tin ligase was recently demonstrated to cause proteasomal
degradation of G9a (Takahashi et al., 2012). To investigate
whether APC/CCdh1 ubiquitin ligase is involved in the degrada-
tion of G9a during ESC differentiation, we performed overex-
pression of Cdh1, an activator of APC/C, in ESCs. Cdh1
expression decreased G9a protein expression at D1.5 in control
(Dox+). When PKA was activated (Dox), G9a protein expres-
sion was increased and interestingly, the level of G9a protein
was not decreased even with induction of Cdh1 expression
(Figure S6D). Some reports have shown that the function
of APC/CCdh1 ubiquitin ligase is inhibited by the cAMP/PKA
pathway (Yamashita et al., 1996; Yamada et al., 1997), suggest-
ing that PKA should inhibit the function of APC/CCdh1 ubiquitin
ligase thereby decreasing degradation of G9a. These evidences
suggest that PKA should increase G9a protein during ESC differ-
entiation not through transcriptional regulation with CREB,
but posttranslational regulation with inhibition of APC/CCdh1
ubiquitin ligase.
Mouse ESCs are able to maintain pluripotency in the presence
of LIF by the transcriptional regulatory circuit with genes such as
Oct3/4, Nanog, and Sox2 (Nishiyama et al., 2009; Takahashi and
Yamanaka, 2006; Walker et al., 2009; Arnold and Robertson,
2009; Ng and Surani, 2011). Given that PKA activation as well
as G9a deletion did not affect the undifferentiated status of
ESCs (Figure S2) in the maintenance condition with LIF, PKA
and G9a cannot interfere or break down the pluripotent tran-
scriptional circuit in the presence of LIF. Some protective mech-
anisms from epigenetic silencing of pluripotent genes should be
working during the undifferentiated state (Ng and Surani, 2011).
For example, H3K9 demethylases, Jmid1a and Jmid2c, were
reported to prevent the accumulation of repressive methylation
at the promoters of genes that maintain pluripotency of ESCs
(Loh et al., 2007). After exit from such protective machinery in
the undifferentiated state, G9a should be able to silence pluripo-
tent genes through PKA activation. Though Oct3/4 but not
Nanog was reported to be silenced by G9a (Feldman et al.,
2006), PKA activation induced epigenetic silencing of Oct3/4
and Nanog, both of which were abolished by G9a deletion
(Figures 4D–4F, 5L, and 5M). Moreover, Nanog expression was
increased by G9a inhibition or deletion in vivo (Figures 6C, 6D,
and 6I). Taken together, these results indicate that G9a should
be a key factor in the silencing of pluripotent genes at early differ-
entiation stages.
Here, we report that the machinery for differentiation timing
consists of a direct molecular link between PKA signaling and
epigenetic control and was independently regulated from that
for cell-fate determination and cell division. Meshorer et al. re-
ported that although undifferentiated ESCs have diffuse hetero-
chromatin structure in the nuclei, differentiation processes cause
reshaping of the global genomic architecture, particularly the
reorganization of compact heterochromatin (Meshorer et al.,
2006; Meshorer and Misteli, 2006). We speculate that PKA criti-
cally regulates the kinetics of compact heterochromatin forma-
tion throughG9a expression (see Graphical Abstract). Of course,
the regulatory mechanisms for differentiation timing would be
variable depending on cell types and differentiation stages.
Nevertheless, elucidation of this critical molecular linkage forCell Stem Cell 10, 759–770, June 14, 2012 ª2012 Elsevier Inc. 765
Figure 5. Effects of PKA on Early Differentiation Are Dependent on G9a
(A) Experimental system for PKA activation and loss of G9a. An ESC line expressing CA-PKA via a tetracyclin-inducible expression system (Tet-Off) together with
a tamoxifen (OHT)-inducible G9a conditional knockout (cKO) system using a fusion protein (MerCreMer) of Cre protein and amutant estrogen receptor, which has
a single copy of the G9a gene flanked by loxP recombination sites (/flox) (tetCA-PKA/G9a cKO cells).
(B) Western blot for G9a and H3K9me2 during ESC differentiation (Dox+). Upper panels: control (OHT). Lower panels: OHT (150 ng/mL) treatment (OHT+; G9a-
deleted condition).
(C) FACS analysis at D2.5 for PDGFRa+ cell appearance. Left panels: Dox treatment (Dox+). Right panels: Dox-free (Dox; PKA activation). Percentages of
PDGFRa+ in total cells are indicated.
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PKA-G9a for Differentiation Timingdifferentiation timing would provide a clue for understanding and
dissecting how cell differentiation and developmental processes
are synchronized and orchestrated. Shedding light on the timing
of the cell differentiation and elucidating and manipulating the
machinery at the molecular level would largely contribute to
basic stem cell and developmental biology as well as, more
broadly, to applied regenerative medicine.
EXPERIMENTAL PROCEDURES
Antibodies
Monoclonal antibody (MoAb) for murine Flk1 (AVAS12) was prepared as
described previously (Nishikawa et al., 1998). MoAb for Oct3/4 was
purchased from Santa Cruz (Santa Cruz, CA, USA). MoAb for Nestin was
purchased from StemCell Technologies (Vancouver, Canada). MoAb for
PDGFRa was purchased from eBioscience (San Diego, CA, USA). MoAb for
b-actin was purchased from Sigma (St. Louis, MO, USA). MoAb for SSEA-1
and the polyclonal antibodies for Brachyury and Sox17 were purchased
from R&D Systems (Minneapolis, MN, USA). The polyclonal antibody for
Nanog was purchased from ReproCell (Tokyo, Japan). Polyclonal antibodies
for Foxa2, trimethyl-Histone H3 (Lys9), and trimethyl-Histone H3 (Lys27)
were purchased from Millipore (Billerica, MA, USA). Polyclonal antibodies
for PKA catalytic subunit a, G9a, and trimethyl-Histone H3 (Lys4) were
purchased from Cell Signaling (Danvers, MA, USA). The polyclonal antibody
for dimethyl-Histone H3 (Lys9) was purchased from Abcam (Cambridge,
UK). Polyclonal antibodies for Nestin and Foxa2 for FACS analysis were
purchased from Bioss (Woburn, MA, USA).
ESC Lines
An ESC line carrying a tetracycline-regulatable constitutively active form of the
PKA (CA-PKA) gene in EStTA-ROSA cells was generated as described previ-
ously (Yamamizu et al., 2009). To generate an ESC line carrying both CA-PKA
and a 4-hydroxytamoxifen (OHT)-regulated G9a conditional KO system, we
constructed a plasmid carrying the tetracycline transactivator (tTA) and the
puromycin-resistant gene and both CA-PKA and red fluorescent protein
(RFP) under the control of the tetracycline-responsive-element-regulatable
cytomegalovirus (BiTRE) promoter (tetCA-PKA) (Figure S3A). We introduced
the tetCA-PKA plasmid into G9a conditional KO ESC line (Yokochi et al.,
2009), using the mouse ESC Nucleofector Kit (Lonza, Basel, Swizerland)
(Figures 5A and S3A). Cells were plated on 10 cm dishes containing 1 mg/ml
doxycycline (Dox+). After 1 day, the medium was changed to Dox+ medium
containing 1 mg/ml puromycin for selection of puromycin-resistant colonies
(tetCA-PKA/G9a cKO cells). The induction of CA-PKA was checked by the
expression of RFP. RFP+ cells were purified after transient treatment in the
Dox condition for 2 days in the presence of LIF; then, purified cells were
maintained again in the Dox+ condition (Figure S3B). RFP+ cells were success-
fully induced in more than 85% of total cells by Dox depletion during differen-
tiation (Figure S3C).
Cell Culture and Differentiation
ESC lines were maintained as described elsewhere (Yamashita et al., 2000;
Yamamizu et al., 2009; Yamamizu et al., 2010). Differentiation was induced
in ESC lines with the use of differentiation medium (DM) [alpha minimal essen-
tial medium (MEM; GIBCO Grand Island, NY, USA) supplemented with 10%
fetal calf serum (FCS; Japan Bioserum, Tokyo, Japan) and 53 105 M 2-mer-(D) Immunostaining for Brachyury (green) at D2.5.
(E) qPCR showing Brachyury, Flk1, or PDGFRa mRNA expression with OHT trea
(F) Immunostaining for Foxa2 (green) at D2.5.
(G) qPCR showing Foxa2 and Sox17 mRNA expression with OHT treatment.
(H) Immunostaining for Nestin at D2.5.
(I) qPCR showing Nestin and Fgf5 mRNA expression with OHT treatment.
(J) Immunostaining for Oct3/4 (green) at D3.5.
(K) qPCR showing Oct3/4, Nanog, or Sox2 mRNA expression with OHT treatme
(L and M) DNA methylation in the promoter regions of Oct3/4 (L) and Nanog (M)captoethanol (2-ME; GIBCO)] as described previously (Yamashita et al., 2000;
Yamamizu et al., 2009; Yamamizu et al., 2010). Treatment of 1 mg/ml Doxycy-
cline (Dox) did not affect differentiation in control ESCs (EStTA-ROSA cells;
Yamamizu et al., 2009), whereas the acceleration of three germ layer genes
was observed similarly in another independent CA-PKA transgenic ESC clone
(clone no. 2) (Figure S7). Differentiated cells were examined by immunostaining
and flow cytometric analysis.
FACS Analysis
Cultured cells were harvested in DM at D1.5, D2.5, and D3.5 after differentia-
tion and stained with combinations of APC-conjugated AVAS12 MoAb,
PE-conjugated anti-SSEA MoAb (R&D Systems), PE-conjugated anti-
PDGFRa MoAb (eBioscince), or Biotin-conjugated anti-PDGFRa MoAb
(eBioscience) followed by streptavidin-conjugated APC (BD PharMingen,
San Diego, CA, USA), and they were then subjected to analysis with FACS
Aria (Becton Dickinson, Franklin Lakes, NJ, USA). For intracellular proteins,
cultured cells were fixed with 4% paraformaldehyde and washed by PBS
with 5% FCS and 0.75% Saponin (Sigma) (Uosaki et al., 2011). Fixed cells
were stained with PE-conjugated anti-Foxa2 or Nestin antibody (Bioss) and
then subjected to analysis with FACS Aria (Becton Dickinson).
Immunohistochemistry and Alkaline Phosphatase Staining
Immunostaining for cultured cells was carried out as described previously
(Yamashita et al., 2000; Yamamizu et al., 2009; Yamamizu et al., 2010). In
brief, 4%-paraformaldehyde-fixed cells were blocked by 1% skim milk (BD
Biosciences) and incubated overnight with primary antibodies at 4C. For
immunofluorescence staining, anti-mouse, -rat, -rabbit, or -goat IgG anti-
bodies conjugated with Alexa488 or Alexa546 (Invitrogen) were used as
secondary antibodies. Nuclei were visualized with DAPI (Invitrogen). Stained
cells were photographed with inverted fluorescent microscopy (Eclipse
TE2000-U, Nikon, Tokyo, Japan) and a digital camera system (AxioCam
HRc) with the use of AxioVision 4.7.1 Software (Carl Zeiss, Jena, Germany).
For oocytes and preimplantation embryo staining, oocytes and embryos at
various developmental stageswere fixedwith 4%paraformaldehyde, permea-
bilized for 30 min with 0.5% Triton X-100 in PBS, blocked for 1 hr in blocking
buffer (1.5% BSA in PBS), and subsequently incubated overnight with primary
antibodies at 4C. For immunofluorescence staining, anti-mouse or -rabbit IgG
antibodies conjugated with Alexa488 or Alexa546 (Invitrogen) were used as
secondary antibodies. Nuclei were visualized with Hoechst 33342 (Sigma-
Aldrich). Fluorescence microscopy was used for the observation of fluores-
cence (BZ-9000, Keyence, Osaka, Japan).
For alkaline phosphatase staining, differentiated cells were fixed with 4%
paraformaldehyde, washed once in PBS, and stained with NBT/BCIP solution
(Roche, Mannheim, Germany). Undifferentiated ESC colonies, partially differ-
entiated cell colonies, and totally differentiated cell colonies were evaluated by
AP staining. ‘‘Undifferentiated’’ indicates AP-positive cell only, ‘‘partially differ-
entiated’’ indicates a mixture of AP-positive and -negative cells, and ‘‘totally
differentiated’’ indicates AP-negative cell only.
Measurement of Intracellular cAMP
Undifferentiated ESCs or differentiated cells were lysed in lysis buffer. We
measured protein concentration with the Qubit Protein Assay Kit (Invitrogen).
The intracellular cAMP concentration was evaluated in protein (1 ng) with the
cAMP-Screen System (Applied Biosystem), according to the manufacturer’s
instructions. Luminescence was measured with a microplate reader (ARVO
MX; PerkinElmer, Waltham, MA, USA).tment during ESC differntiation. Blue lines, Dox+; red lines, Dox.
nt.
at D5.5. Scale bars represent 200 mm.
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Figure 6. Inhibition of PKA- or G9a-Induced Sus-
tained Pluripotent Gene Expression and Delayed
Development In Vivo
(A) Immunostaining for PKA catalytic subunit (PKAc)
(green) in oocytes and preimplantation embryos.
(B) qPCR showing PKAc mRNA expression during early
embryogenesis.
(C and D) Effects of H89 (3 mM) or BIX01294 (0.5 mM) on
Nanog expression in early ex vivo embryo culture (1.5 days
from E3.25 stage). (C) Immunostaining for Nanog (green)
and DAPI (blue). Scale bar represents 25 mm. (D) Quanti-
tative evaluation of Nanog+ cell percentages in total cells
(control; n = 11, H89; n = 15, BIX01294; n = 13, *p < 0.05
versus control).
(E and F) Effects of H89 or BIX01294 on the primitive
endoderm development in ex vivo culture. (E) Double im-
munostaining for Oct3/4 (red) and Gata4 (green). Note that
a clear array of GATA4+ primitive endoderm is observed in
controls. Oct3/4 is positive for both ICM and primitive
endoderm. Scale bar represents 25 mm. (F) Quantitative
evaluation of Oct3/4+ or Gata4+ cell percentages in total
cells (upper and middle panels) and total cell number in
each embryo (lower panel) (control; n = 12, H89; n = 13,
BIX01294; n = 12, *p < 0.05, **p < 0.01 versus control).
(G) in situ hybridization for Oct3/4 at E6.5 in a WT embryo
(purple). Scale bars represent 500 mm (left) or 100 mm
(right).
(H) In situ hybridization for Oct3/4 or Flk1 (purple) in E7.5
embryos. Upper panels: WT. Lower panels: G9a KO
embryos. Arrow indicates a trace Oct3/4 expression in
WT. Arrowheads indicate sustained Oct3/4 expression in
G9a KO embryo. Scale bars represent 100 mm.
(I) qPCR showing G9a, Oct3/4, Nanog, or Flk1 mRNA
expression in E7.5 embryos (n = 3 from independent
pregnant mice, **p < 0.01 versus WT).
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A DNA fragment corresponding to a nucleotide sequence in mouse Oct3/4
(GenBank accession number NM_013633) or Flk1 gene (GenBank accession
number NM_010612) was subcloned into pGEMT-Easy vector (Promega)
and was used for generation of sense or antisense RNA probes (Table S1).
Paraffin-embedded embryo sections (6 mm) of C57BL/6 mouse (Sankyo
Labo Service) or G9a KO mice were obtained from Genostaff (Tokyo, Japan).
For in situ hybridization, the sections were hybridized with digoxigenin-labeled
RNA probes at 60C for 16 hr. The bound label was detected with NBT-BCIP,768 Cell Stem Cell 10, 759–770, June 14, 2012 ª2012 Elsevier Inc.an alkaline phosphate color substrate. The sections were
counterstained with Kernechtrot (Muto Pure Chemicals,
Tokyo, Japan). Stained cells were photographed with an
inverted fluorescence microscope (Leica DM2500; Leica,
Tokyo, Japan) and a digital camera system (COOLPIX995;
Nikon).
Western Blotting
Western blotting was performed as previously described
(Yamamizu et al., 2009; Yamamizu et al., 2010). In brief,
undifferentiated and differentiated cells were lysed in lysis
buffer, and the samples were run on SDS-PAGE with the
use of gradient gel (Atto, Tokyo, Japan), followed by elec-
trophoretic transfer onto nitrocellulose membranes. After
the blots were incubated for 1 hr in the blocking agent
Blocking One (Nacalai Tesque, Kyoto, Japan), they were
incubated overnight with the respective primary anti-
bodies at 4C. Anti-mouse or -rabbit IgG antibodies conju-
gated with Horseradish peroxidase (HRP) was used as
secondary antibodies (1:10,000). The Can Get Signal Im-munoreaction Enhancer Solution Kit (Toyobo, Osaka, Japan) was used for
signal enhancement. Immunoreactivity was detected with the enhanced
chemiluminescence kit Chemi-Lumi One (Nacalai Tesque). Signal intensity
was calculated with Scion Image software (Scion, Frederick, MD, USA).
Chromatin Immunoprecipitation Assay
Immunostaining for cultured cells was carried out as described previously (Ya-
mamizu et al., 2010). In brief, after 1.5, 2.5, and 3.5 days, differentiatied cells
were subjected to crosslinking with 3.7% formaldehyde, followed by ChIP
Figure 7. Molecular Linkages Regulating Differentiation Timing in
Early ESC Differentiation and Embryogenesis
PKA signaling accelerates differentiation timing from mouse ESCs and early
embryos through regulation of G9a, H3K9 methyltransferase. AM is one of the
endogenous ligands that activates cAMP/PKA signaling for the regulation of
ESC differentiation timing. PKA increases G9a protein during ESC differenti-
ation through posttranslational regulation with the inhibition of APC/CCdh1
ubiquitin ligase. G9a modifies H3K9me2 and DNA methylation in the promoter
region of Oct3/4 and Nanog, thereby inhibiting Oct3/4 and Nanog expression.
This direct molecular linkage of signaling molecules (PKA signaling), epige-
netic modifiers (G9a), gene expressions (Oct3/4 and Nanog), and cell behavior
(cell differentiation) forms a machinery regulating cell-differentiation timing in
early ESC differentiation and in vivo embryonic development.
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PKA-G9a for Differentiation Timingassay via a ChIP Assay Kit (Millipore). Chromatin was sheared to an average
length of 0.4–1.0 kb. Antibodies to dimethyl-Histone H3 (Lys9) (Abcam) were
used for immunoprecipitation. Sets of primers were used to amplify DNA
sequences (Table S2). PCR amplification was conducted with a variable
number of cycles (94C for 30 s, 60C for 30 s, and 72C for 30 s).
Bisulfite Genomic Sequencing
Total DNA was isolated from undifferentiated ESCs and differentiated cells
with the use of the DNeasy Tissue Kit (QIAGEN, Valencia, CA, USA) according
to the manufacturer’s instructions. Bisulfite treatment was performed with the
CpGenome Modification Kit (Chemicon) according to the manufactuer’s
recommendations. PCR products were gel purified with the QIAquick Gel
Extraction Kit (QIAGEN) and cloned into T-Vector (Novagen, Darmstadt,
Germany) with Ligation high (Toyobo). Ten random clones were picked and
sequenced with T7 or U-19-mer primer. PCR primers are listed in Table S2
(Imamura et al., 2006; Takahashi and Yamanaka, 2006).RNA Isolation, RT-PCR, and qPCR
Total RNA was isolated from undifferentiated ESCs, differentiated cells,
oocytes, fertilized embryos before implantation, and E7.5 embryos with the
use of RNeasy (QIAGEN) according to the manufacturer’s instructions.
Reverse transcription was performed with the SuperScript III First-Strand
Synthesis System (Invitrogen). qPCR was performed with Power SYBR Green
PCR Master Mix (Applied Biosystems, San Diego, CA) and a StepOnePlus
system (Applied Biosystems). The amount of target RNA was determined
from the appropriate standard curve and normalized relative to the amount
of Gapdh mRNA. Primer sequences are shown in Table S3.
Collection and Culture of Oocytes and Embryos
All animal experiments were performed in accordance with the guidelines for
Animal Experiments of Kyoto University, which conform to the Guide for the
Care and Use of Laboratory Animals in Japan. Mouse oocytes and preimplan-
tation embryos were collected as previously described (Tsukamoto et al.,
2006). In brief, 6- or 7-week-old female Crj; CD-1 (ICR) mice (Shimizu Labora-
tory Supplies, Kyoto, Japan) were superovulated by intraperitoneal (i.p.) injec-
tion of 5 IU eCG (ASKA Pharmaceutical, Tokyo, Japan), followed 46 hr later by
5 IU hCG (Sankyo Zoki, Tokyo, Japan). Unfertilized metaphase II (MII) oocytes
were collected 16 hr after hCG from the oviductal ampullae. Fertilized embryos
were recovered at 20 hr (1-cell stage) after hCG injection from the oviductal
ampullae, or at E3.25 from the uterus, respectively. Collected embryos were
cultured in vitro in KSOMmedia (EmbryoMax,Millipore) to the blastocyst stage
for immunohistochemical staining. The E3.25 embryos were cultured in KSOM
media with various reagents, PKA inhibitor, H89 and G9a inhibitor, and
BIX01294 for 1.5 days. After 1.5 days, cultured embryos were examined by
immunohistochemistry.
G9a Knockout Mice
Generation of the G9a KO mice was carried out as described previously
(Tachibana et al., 2002). Mice were allowed to mate naturally at night.
E0.5 was considered to be noon on the day a vaginal plug was observed.
Embryos at E6.5 and E7.5 were subjected to in situ hybridization and
qPCR.
Statistical Analysis
At least three independent experiments were performed. Statistical analysis of
the data was performed with an ANOVA; p < 0.05 was considered significant.
Values are reported as means ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, three tables, and two movies and can be found with this article
online at doi:10.1016/j.stem.2012.02.022.
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